We Are BrainCool
BrainCool Inc is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. The company focuses on two business segments, Brain Cooling and Pain Management.
The IQool™ System
The IQool™ System is a medical device that monitors and controls a patient’s temperature between 33℃ – 38.5℃. BrainCool AB has received 501(k) clearance from the US Food and Drug Administration (FDA) to market the product in the United States. The user friendly advanced temperature management system provides an indication for use of thermal regulation to cool and rewarm adult patients when clinically indicated.
Latest News
Stay up to date with the latest news from BrainCool
BrainCool AB (publ) obtains patent approval in Japan for shivering application of the BrainCool™ System
The Japanese Patent Office has announced that it has decided to grant BrainCool's technology to detect shivering for the product BrainCool ™ System patent approval in Japan.
Management changes in BrainCool AB
BrainCool AB (publ) (together with its subsidiary BrainCool Inc.), an innovative Swedish medical device company with focus on temperature management today announced two management changes.
BrainCool Ab (publ) Completes Patient Recruitment in a Scandinavian Pivotal Trial for FDA Clearance of Oral Mucositis Treatment in the United States
BrainCool Ab (publ) Completes Patient Recruitment in a Scandinavian Pivotal Trial for FDA Clearance of Oral Mucositis Treatment in the United States. Intra-Oral Cooling Device is Tested in 180 Patients to Eliminate Oral Mucositis (OM), One of the Severest Side-Effects of Radiology and Chemotherapy for Blood, Bone or Solid Tumor Cancer Treatment